Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-15
DOI
10.1038/srep42632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle biointerfacing by platelet membrane cloaking
- (2015) Che-Ming J. Hu et al. NATURE
- Doxorubicin loaded chitosan–ZnO hybrid nanospheres combining cell imaging and cancer therapy
- (2015) Huiyue Zhao et al. RSC Advances
- Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
- (2014) Melissa Howard et al. ACS Nano
- The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin
- (2014) Shuai Shi et al. BIOMATERIALS
- Co-opting biology to deliver drugs
- (2014) Parisa Yousefpour et al. BIOTECHNOLOGY AND BIOENGINEERING
- Carrier erythrocytes: recent advances, present status, current trends and future horizons
- (2014) Abdolhossein Zarrin et al. Expert Opinion on Drug Delivery
- RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
- (2014) Fangfang Wang et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticles as drug delivery systems
- (2014) Agnieszka Z. Wilczewska et al. Pharmacological Reports
- Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
- (2013) Qi Yin et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers
- (2013) Xiuli Yue et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma
- (2013) Ommoleila Molavi et al. BIOMATERIALS
- Drug Delivery Using Platelet Cancer Cell Interaction
- (2013) Sounik Sarkar et al. PHARMACEUTICAL RESEARCH
- A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies
- (2013) Kathryn Chapman et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-platelet interaction in solid tumors
- (2012) Daniel Buergy et al. INTERNATIONAL JOURNAL OF CANCER
- Biocompatibility of engineered nanoparticles for drug delivery
- (2012) Sheva Naahidi et al. JOURNAL OF CONTROLLED RELEASE
- Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009
- (2011) J. Sjoberg et al. BLOOD
- A Decade of Progress in Lymphoma: Advances and Continuing Challenges
- (2011) Christopher R. Flowers et al. Clinical Lymphoma Myeloma & Leukemia
- Platelets as delivery systems for disease treatments
- (2010) Qizhen Shi et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
- (2009) Jason Park et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting atherosclerosis by using modular, multifunctional micelles
- (2009) D. Peters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
- (2008) Rohit B. Kolhatkar et al. PHARMACEUTICAL RESEARCH
- Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv
- (2007) Wilson W.K. Cheng et al. JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now